Name one post where I have ever ridiculed Cantrixil yet alone persistently. If you can not please remove that post
JG and the other dir are way too professional to ever call a " spade a sapde" type explanation and are no doubt restricted by confidentiality clauses. I expect on HC, however, poster willing to press the envelope with research and analysis that might join the dots. So I will ask again what year were those mice tested with the NOX66 formulation as described in the description section found at patentscop
Example 1 Plasma pharmacokinetic studies of idronoxil in rats
"1 . OBJECTIVE
The objective of this study in rodents is to determine the plasma pharmacokinetics of idronoxil after rectal delivery and intestinal delivery in lipids (cocoa butter or emulsion).
2. STUDY DESIGN
Plasma pharmacokinetic studies rats
Part (1 ); n=3 rats: Rectal administration of idronoxil in cocoa butter liquid formulation, collection of plasma.
How about engaing the question istead of juct whining that some has the audicidty to ask a question. In fact I am most likely barking up the wonrg tree to which anyone would simple type a year, with a link proving it. It could be something else that was disputed such as this line......
If it is that wording of related isoflavonoids that was being challenged and now handed over I would have thought NOX poster would be thrilled at the prospect of a widened horizon of potential.
If I am hard on NOX it more likely I have a vendetta against posters who look more like The Stepford wives than serious debaters.
NOX Price at posting:
$1.24 Sentiment: None Disclosure: Not Held
(20min delay)
